Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 mai 2026 06h46 HE | Source: Bleichmar Fonti & Auld

Investor Notice: Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action

Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action
29 avr. 2026 06h36 HE | Source: Bleichmar Fonti & Auld

$MEDP Fraud: Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law

Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law
27 avr. 2026 06h11 HE | Source: Bleichmar Fonti & Auld

Court Reminder: Medpace (NASDAQ:MEDP) June 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law

Medpace (NASDAQ:MEDP) June 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
23 avr. 2026 12h12 HE | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
17 avr. 2026 09h33 HE | Source: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
13 avr. 2026 05h59 HE | Source: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
07 avr. 2026 18h50 HE | Source: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit – RGRD Law

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.